Navigation Links
Atrium Recognized by Business NH Magazine
Date:9/8/2010

HUDSON, N.H., Sept. 8 /PRNewswire/ -- Atrium Medical Corporation is proud to announce that it has been recognized by Business NH Magazine's September 2010 publication of Top 100 Private Companies in New Hampshire. The company has been ranked #12 of the fastest growing private firms in NH, and #9 overall in corporate revenue rankings based on last year's 2009 reported revenues. Atrium has placed prominently among the state's Top 100 private firms in size and rate of growth for the third year in a row.

According to the company's founder and CEO Steve Herweck, "Extraordinary profit and earnings growth, as well as incredible employee growth over the last 5 years is a result of management's commitment to organic and self funded developments in a broad spectrum of clinically relevant medical device technologies." These market leading products include proprietary items in Interventional Cardiology and Radiology, Vascular Surgery, BioSurgery, and Thoracic Surgery which are all designed, engineered and produced at its Hudson, New Hampshire manufacturing facility.

As Atrium approaches its 30th anniversary in early 2011 with plans for continued expansion in southern New Hampshire, this most recent corporate recognition affirms the company's MedTech legacy of enhanced patient outcomes in a highly regulated and diversified healthcare industry. The company's passion for innovation and quality are supported by its internally funded developments in innovation, employee training and advancement, evidence-based clinical trials, global logistics, state-of-the-art enterprise software operations and world class manufacturing.  

About Atrium

Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and hernia repair. By maintaining a commitment to the latest ISO13485 Quality Standards, late breaking advancements in manufacturing and automation, cell biology and biomaterial research, Atrium continues to excel in those healthcare segments that require more advanced surgical intervention for life sustaining patient care. For more information please call Atrium's Marketing Communications Dept. at 1-800-370-7899 or visit Atrium's website at www.atriummed.com.


'/>"/>
SOURCE Atrium Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
2. Atrium Responds to Bard Suit
3. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
4. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
5. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
6. Roche Scientist Recognized for Excellence in Peptide Chemistry
7. SEI Defined Benefit Client Recognized With Leading Plan Design Award
8. Nonin Medical Recognized for Influential Contributions in Medical Technology
9. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
10. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
11. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 17, 2017 According to a new market ... Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End ... by MarketsandMarkets, the market is expected to reach USD 330.6 Million ... of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... , Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: ... U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine ... Hydrocodone bitartrate and homatropine methylbromide oral solution ... the symptomatic relief of cough in adults and children 6 ... months ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017   ... other side effects allegedly associated with use of the ... Philadelphia Court of Common Pleas, ... a mass tort program. According to a notice posted ... scheduled to convene a meeting on March 9, 2017 ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance Healthcare ... designed to further positively impact the health and wellness of our community in ... it our duty to seriously consider releasing our assets beyond our 5% targeted ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — ... Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in and around ... a charity drive to help prevent all forms of domestic violence. , There ...
(Date:2/16/2017)... ... 2017 , ... The Price Agency, a Jefferson County-based firm ... the Birmingham area, is announcing an ongoing charity event to help raise support ... son, Anius. , Anius is medically complex with diagnoses consisting and not limited ...
Breaking Medicine News(10 mins):